GSK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GlaxoSmithKline PLC's quarterly common stock declined from Mar. 2016 ($1,909 Mil) to Jun. 2016 ($1,905 Mil) and declined from Jun. 2016 ($1,905 Mil) to Sep. 2016 ($1,762 Mil).
GlaxoSmithKline PLC's annual common stock increased from Dec. 2012 ($2,179 Mil) to Dec. 2013 ($2,187 Mil) but then declined from Dec. 2013 ($2,187 Mil) to Dec. 2014 ($2,095 Mil).
Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.
The par value of common stocks is meaningless. It is usually set at an absurdly low number.
GlaxoSmithKline PLC Annual Data
GlaxoSmithKline PLC Quarterly Data